ABSTRACT
T follicular helper (Tfh) cells are critical for providing the necessary signals to induce differentiation of B cells into memory and Ab-secreting cells. Accordingly, it is important to identify the molecular requirements for Tfh cell development and function. We previously found that IL-12 mediates the differentiation of human CD4(+) T cells to the Tfh lineage, because IL-12 induces naive human CD4(+) T cells to acquire expression of IL-21, BCL6, ICOS, and CXCR5, which typify Tfh cells. We have now examined CD4(+) T cells from patients deficient in IL-12Rß1, TYK2, STAT1, and STAT3 to further explore the pathways involved in human Tfh cell differentiation. Although STAT1 was dispensable, mutations in IL12RB1, TYK2, or STAT3 compromised IL-12-induced expression of IL-21 by human CD4(+) T cells. Defective expression of IL-21 by STAT3-deficient CD4(+) T cells resulted in diminished B-cell helper activity in vitro. Importantly, mutations in STAT3, but not IL12RB1 or TYK2, also reduced Tfh cell generation in vivo, evidenced by decreased circulating CD4(+)CXCR5(+) T cells. These results highlight the nonredundant role of STAT3 in human Tfh cell differentiation and suggest that defective Tfh cell development and/or function contributes to the humoral defects observed in STAT3-deficient patients.
Subject(s)
Cell Differentiation , Interleukin-12/pharmacology , Mutation/genetics , Receptors, Interleukin-12/genetics , STAT1 Transcription Factor/genetics , STAT3 Transcription Factor/genetics , T-Lymphocytes, Helper-Inducer/cytology , TYK2 Kinase/genetics , Animals , B-Lymphocytes/cytology , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , Cells, Cultured , Cytokines/metabolism , Humans , Immunocompromised Host , Lymphocyte Activation , Mice , Receptors, Interleukin-12/deficiency , STAT1 Transcription Factor/metabolism , STAT3 Transcription Factor/deficiency , Signal Transduction , T-Lymphocytes, Helper-Inducer/immunology , T-Lymphocytes, Helper-Inducer/metabolism , TYK2 Kinase/metabolism , Transcription Factors/metabolismABSTRACT
BACKGROUND: The capacity of CD8(+) T cells to control infections and mediate antitumor immunity requires the development and survival of effector and memory cells. IL-21 has emerged as a potent inducer of CD8(+) T-cell effector function and memory development in mouse models of infectious disease. However, the role of IL-21 and associated signaling pathways in protective CD8(+) T-cell immunity in human subjects is unknown. OBJECTIVE: We sought to determine which signaling pathways mediate the effects of IL-21 on human CD8(+) T cells and whether defects in these pathways contribute to disease pathogenesis in patients with primary immunodeficiencies caused by mutations in components of the IL-21 signaling cascade. METHODS: Human primary immunodeficiencies resulting from monogenic mutations provide a unique opportunity to assess the requirement for particular molecules in regulating human lymphocyte function. Lymphocytes from patients with loss-of-function mutations in signal transducer and activator of transcription 1 (STAT1), STAT3, or IL-21 receptor (IL21R) were used to assess the respective roles of these genes in human CD8(+) T-cell differentiation in vivo and in vitro. RESULTS: Mutations in STAT3 and IL21R, but not STAT1, led to a decrease in multiple memory CD8(+) T-cell subsets in vivo, indicating that STAT3 signaling, possibly downstream of IL-21R, regulates the memory cell pool. Furthermore, STAT3 was important for inducing the lytic machinery in IL-21-stimulated naive CD8(+) T cells. However, this defect was overcome by T-cell receptor engagement. CONCLUSION: The IL-21R/STAT3 pathway is required for many aspects of human CD8(+) T-cell behavior but in some cases can be compensated by other signals. This helps explain the relatively mild susceptibility to viral disease observed in STAT3- and IL-21R-deficient subjects.
Subject(s)
CD8-Positive T-Lymphocytes/cytology , Cell Differentiation , Immunologic Memory , Job Syndrome/genetics , Mutation , STAT3 Transcription Factor/metabolism , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Cell Differentiation/genetics , Cell Differentiation/immunology , Humans , Interleukins/genetics , Interleukins/immunology , Interleukins/metabolism , Job Syndrome/immunology , Job Syndrome/pathology , Receptors, Interleukin-21/genetics , Receptors, Interleukin-21/immunology , Receptors, Interleukin-21/metabolism , STAT3 Transcription Factor/geneticsABSTRACT
Germline mutations in five autosomal genes involved in interleukin (IL)-12-dependent, interferon (IFN)-gamma-mediated immunity cause Mendelian susceptibility to mycobacterial diseases (MSMD). The molecular basis of X-linked recessive (XR)-MSMD remains unknown. We report here mutations in the leucine zipper (LZ) domain of the NF-kappaB essential modulator (NEMO) gene in three unrelated kindreds with XR-MSMD. The mutant proteins were produced in normal amounts in blood and fibroblastic cells. However, the patients' monocytes presented an intrinsic defect in T cell-dependent IL-12 production, resulting in defective IFN-gamma secretion by T cells. IL-12 production was also impaired as the result of a specific defect in NEMO- and NF-kappaB/c-Rel-mediated CD40 signaling after the stimulation of monocytes and dendritic cells by CD40L-expressing T cells and fibroblasts, respectively. However, the CD40-dependent up-regulation of costimulatory molecules of dendritic cells and the proliferation and immunoglobulin class switch of B cells were normal. Moreover, the patients' blood and fibroblastic cells responded to other NF-kappaB activators, such as tumor necrosis factor-alpha, IL-1beta, and lipopolysaccharide. These two mutations in the NEMO LZ domain provide the first genetic etiology of XR-MSMD. They also demonstrate the importance of the T cell- and CD40L-triggered, CD40-, and NEMO/NF-kappaB/c-Rel-mediated induction of IL-12 by monocyte-derived cells for protective immunity to mycobacteria in humans.
Subject(s)
CD40 Antigens/physiology , Genes, X-Linked , Genetic Predisposition to Disease , I-kappa B Kinase/genetics , Interleukin-12/biosynthesis , Mycobacterium Infections/genetics , Mycobacterium Infections/immunology , X Chromosome , Adolescent , Adult , Animals , Cell Line, Transformed , Cells, Cultured , Child , Child, Preschool , Female , Humans , Infant , L Cells , Male , Mice , PedigreeABSTRACT
BACKGROUND: Interferon-gamma (IFN-γ) release assays (IGRAs) are suboptimally sensitive to diagnose tuberculosis (TB) and latent TB infection (LTBI) in young children. In this study we compared Mycobacterium tuberculosis antigen-stimulated IFN-γ inducible protein 10 (IP-10) responses in children with active TB and LTBI to responses from children with non-tuberculous mycobacterial (NTM) lymphadenopathy and respiratory tract infection (RTI). We also assessed test agreement between IP-10 and the QuantiFERON(®)-TB Gold In-Tube (QFT-IT) test results, and investigated whether IP-10 release upon mitogen stimulation is associated with age. METHODS: We recruited 48 children (median age 54 months) diagnosed in Germany with either active TB (n = 11), LTBI (n = 14), NTM lymphadenopathy (n = 8), or common RTI (n = 15). IFN-γ levels were measured using the QFT-IT. These plasma supernatants were used to determine IP-10 concentrations using an in-house enzyme-linked immunosorbent assay (ELISA). RESULTS: The median antigen-stimulated IP-10 levels in children with active TB, LTBI, NTM lymphadenopathy, and RTI were 12,702 pg/ml, 9109 pg/ml, 97 pg/ml, and 84 pg/ml, respectively. We observed a strong correlation between IP-10 and IFN-γ plasma concentration in children with active TB and LTBI (r(2) = 0.69). Overall agreement between IP-10 and QFT-IT assays was high (kappa = 0.95). IP-10 levels after mitogen stimulation showed no association with age. CONCLUSIONS: IP-10 and IFN-γ were both induced with antigen stimulation in blood from children in the TB and LTBI groups, in contrast to the NTM and RTI groups. Compared to IFN-γ the IP-10 levels were higher and IP-10 was released independently of age. IP-10 therefore may represent an additional biomarker in the paediatric population.
Subject(s)
Chemokine CXCL10/metabolism , Immunologic Tests/methods , Latent Tuberculosis/metabolism , Tuberculosis/metabolism , Antigens, Bacterial/immunology , Biomarkers/analysis , Biomarkers/blood , Biomarkers/metabolism , Case-Control Studies , Chemokine CXCL10/analysis , Chemokine CXCL10/blood , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay/methods , Female , Humans , Infant , Interferon-gamma/analysis , Interferon-gamma/blood , Interferon-gamma/metabolism , Interferon-gamma Release Tests , Latent Tuberculosis/blood , Latent Tuberculosis/diagnosis , Latent Tuberculosis/immunology , Lymphatic Diseases , Male , Reagent Kits, Diagnostic , Respiratory Tract Infections , Statistics, Nonparametric , Tuberculosis/blood , Tuberculosis/diagnosis , Tuberculosis/immunologyABSTRACT
Life-threatening disseminated tuberculosis developed in a 17-year-old girl who was treated with the TNF-α blocker adalimumab for refractory SAPHO syndrome. The patient presented to the emergency department with dyspnea and somnolence and within 2 h developed the clinical picture of a septic shock. In addition to this unusual presentation, she showed a complicated course with increasing cerebral granuloma formation in spite of adequate antimycobacterial treatment. Immune reconstitution after discontinuation of TNF blockade may contribute to this "paradoxical reaction." Possible implications for screening, diagnosis, and treatment of tuberculosis in children and adolescents receiving anti-TNF treatment are discussed.
Subject(s)
Acquired Hyperostosis Syndrome/drug therapy , Antibodies, Monoclonal, Humanized/adverse effects , Immunocompromised Host , Immunosuppressive Agents/adverse effects , Tuberculosis, Miliary/diagnosis , Tuberculosis, Miliary/immunology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Acquired Hyperostosis Syndrome/immunology , Adalimumab , Adolescent , Anti-Inflammatory Agents/adverse effects , Antitubercular Agents/therapeutic use , Aza Compounds/therapeutic use , Drug Therapy, Combination , Dyspnea/microbiology , Ethambutol/therapeutic use , Female , Fluoroquinolones , Humans , Moxifloxacin , Quinolines/therapeutic use , Severity of Illness Index , Shock, Septic/microbiology , Treatment Outcome , Tuberculosis, Miliary/complications , Tuberculosis, Miliary/drug therapyABSTRACT
Patients infected with human immunodeficiency virus type 1 (HIV-1) are considered to be at increased risk for 2009 H1N1 influenza-related complications. We performed an observational study after an outbreak of 2009 H1N1 influenza virus infection among a group of 15 HIV-1-infected school-aged children in Germany in October 2009. Clinical course, kinetics of viral shedding, and antibody response among children with CD4 cell counts >350 cells/µL and 2009 H1N1 influenza virus coinfection did not appear to differ from that among healthy children. Oseltamivir shortened the duration of viral shedding.
Subject(s)
Disease Outbreaks , HIV Infections/complications , Influenza A Virus, H1N1 Subtype/isolation & purification , Influenza, Human/epidemiology , Adolescent , Antibodies, Viral/blood , Antiviral Agents/therapeutic use , CD4 Lymphocyte Count , Child , Female , Germany/epidemiology , HIV Infections/virology , HIV-1/isolation & purification , Humans , Influenza, Human/drug therapy , Influenza, Human/pathology , Influenza, Human/virology , Male , Oseltamivir/therapeutic use , Treatment Outcome , Virus SheddingABSTRACT
Isoniazid (INH) is one of the most important drugs for the treatment of tuberculosis (TB). In the current international recommendations there is still disagreement on the optimal dosage of INH in childhood TB. This paper presents data from 2 studies, one performed in 1960 and the other in 1961, investigating INH serum levels in children of different age groups, not yet presented internationally. Doses were calculated according to bodyweight (BW) as well as according to body surface area (BSA). In the first study, INH serum levels at different time points in children of different age groups were determined after oral INH administration at 5 mg/kg BW. In the second study, INH serum levels were measured once, 4 h after subcutaneous application of 5 mg/kg BW and once, 4 h after subcutaneous application of INH 200 mg/m(2) BSA 1 week later. These data was compared to adult data on INH collected prior to these studies. After application of 5 mg/kg BW oral dose, INH serum levels were much lower in children than in adults at all time points, especially in children younger than 8 y. In contrast, after dosing according to 200 mg/m(2) BSA, similar serum levels were achieved in children and adults. Dose recommendations of INH 5 mg/kg BW in childhood TB lead to lower serum concentrations than those recommended for adults. In children, it appears to be more appropriate to calculate the INH dose on the basis of body surface area rather than bodyweight.
Subject(s)
Antitubercular Agents/administration & dosage , Antitubercular Agents/pharmacokinetics , Isoniazid/administration & dosage , Isoniazid/pharmacokinetics , Tuberculosis/drug therapy , Administration, Oral , Adolescent , Adult , Child , Child, Preschool , Humans , Infant , Injections, Subcutaneous , Serum/chemistry , Young AdultABSTRACT
The transcription factor signal transducer and activator of transcription-1 (STAT1) plays a key role in immunity against mycobacterial and viral infections. Here, we characterize three human STAT1 germline alleles from otherwise healthy patients with mycobacterial disease. The previously reported L706S, like the novel Q463H and E320Q alleles, are intrinsically deleterious for both interferon gamma (IFNG)-induced gamma-activating factor-mediated immunity and interferon alpha (IFNA)-induced interferon-stimulated genes factor 3-mediated immunity, as shown in STAT1-deficient cells transfected with the corresponding alleles. Their phenotypic effects are however mediated by different molecular mechanisms, L706S affecting STAT1 phosphorylation and Q463H and E320Q affecting STAT1 DNA-binding activity. Heterozygous patients display specifically impaired IFNG-induced gamma-activating factor-mediated immunity, resulting in susceptibility to mycobacteria. Indeed, IFNA-induced interferon-stimulated genes factor 3-mediated immunity is not affected, and these patients are not particularly susceptible to viral disease, unlike patients homozygous for other, equally deleterious STAT1 mutations recessive for both phenotypes. The three STAT1 alleles are therefore dominant for IFNG-mediated antimycobacterial immunity but recessive for IFNA-mediated antiviral immunity at the cellular and clinical levels. These STAT1 alleles define two forms of dominant STAT1 deficiency, depending on whether the mutations impair STAT1 phosphorylation or DNA binding.
Subject(s)
Mycobacterium Infections/genetics , STAT1 Transcription Factor/genetics , Adolescent , Adult , Alleles , Cell Cycle Proteins/metabolism , Cells, Cultured , Child , Child, Preschool , DNA Mutational Analysis , DNA-Binding Proteins/metabolism , Female , GPI-Linked Proteins , Gene Expression Regulation , Genes, Dominant , Genes, Recessive , Heterozygote , Humans , Immunity, Active/genetics , Infant , Interferon-Stimulated Gene Factor 3, gamma Subunit/metabolism , Interferon-alpha/metabolism , Interferon-gamma/metabolism , Male , Membrane Proteins/metabolism , Models, Biological , Models, Molecular , Mutant Proteins/chemistry , Mutation , Mycobacterium Infections/etiology , Pedigree , Protein Binding , STAT1 Transcription Factor/metabolism , Transcription, Genetic , Transfection/methodsABSTRACT
Multifunctional T cells expressing several cytokines in parallel are thought to play a crucial role in protection against different infections. To characterize T cell cytokine patterns associated with disease and protection in Mycobacterium tuberculosis infection we determined the expression of IFNgamma, IL-2, TNFalpha, and GM-CSF in T cell subpopulations from children with tuberculosis (TB) and healthy latently M. tuberculosis-infected children (LTBI) after short-term in vitro restimulation. We identified CD4(+) effector memory T cells (T(EM)) as the major source of all measured cytokines after antigen-specific restimulation. T(EM) from children with TB expressed higher proportions of IFNgamma, TNFalpha, and IL-2 after Mtb restimulation while no differences were detected for GM-CSF between both study groups. GM-CSF secretion strongly depended on antigen-specific stimulation. Analyses of multiple cytokine patterns revealed that the majority of GM-CSF-positive M. tuberculosis-specific memory T cells coexpressed IFNgamma and TNFalpha therefore showing a characteristic feature of multifunctional T cells. We conclude that children with active TB possess higher proportions of IFNgamma-, TNFalpha-, and/or IL-2-positive T(EM) than children with LTBI while GM-CSF coexpression reveals a novel subpopulation within CD4(+) memory T cells not increased in children with active TB.
Subject(s)
CD4-Positive T-Lymphocytes/immunology , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Immunologic Memory/immunology , Interferon-gamma/immunology , Mycobacterium tuberculosis/immunology , Tumor Necrosis Factor-alpha/immunology , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Leukocyte Common Antigens/immunology , Male , Tuberculosis/immunologyABSTRACT
BACKGROUND: In Western Europe, migrants constitute an important risk group for tuberculosis, but little is known about successive generations of migrants. We aimed to characterize migration among tuberculosis cases in Berlin and to estimate annual rates of tuberculosis in two subsequent migrant generations. We hypothesized that second generation migrants born in Germany are at higher risk of tuberculosis compared to native (non-migrant) residents. METHODS: A prospective cross-sectional study was conducted. All tuberculosis cases reported to health authorities in Berlin between 11/2010 and 10/2011 were eligible. Interviews were conducted using a structured questionnaire including demographic data, migration history of patients and their parents, and language use. Tuberculosis rates were estimated using 2011 census data. RESULTS: Of 314 tuberculosis cases reported, 154 (49.0%) participated. Of these, 81 (52.6%) were first-, 14 (9.1%) were second generation migrants, and 59 (38.3%) were native residents. The tuberculosis rate per 100,000 individuals was 28.3 (95CI: 24.0-32.6) in first-, 10.2 (95%CI: 6.1-16.6) in second generation migrants, and 4.6 (95%CI: 3.7-5.6) in native residents. When combining information from the standard notification variables country of birth and citizenship, the sensitivity to detect second generation migration was 28.6%. CONCLUSIONS: There is a higher rate of tuberculosis among second generation migrants compared to native residents in Berlin. This may be explained by presumably frequent contact and transmission within migrant populations. Second generation migration is insufficiently captured by the surveillance variables country of birth and citizenship. Surveillance systems in Western Europe should allow for quantifying the tuberculosis burden in this important risk group.
Subject(s)
Emigrants and Immigrants , Tuberculosis/epidemiology , Adolescent , Adult , Aged , Berlin/epidemiology , Child , Child, Preschool , Cross-Sectional Studies , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Prospective Studies , Young AdultABSTRACT
Timing for the evaluation and listing of patients with cystic fibrosis who are candidates for lung transplantation is still uncertain. Our study goal was to determine the value of the 12-min walk test as a simple and easy-to-use adjunctive assessment tool for pre-transplant evaluation. A total of 34 cystic fibrosis patients (17 male, mean age 22 years) with end-stage lung disease were evaluated in this retrospective analysis. The 12-min walk test was carried out according to an established protocol. Before walking, body plethysmography was performed and a capillary sample was taken for blood gas analysis. Walking distance and SaO(2) via continuous pulse oximetry were recorded online. There was a strong correlation between survival time and walking distance (r=0.7, P=0.003). No other single parameter, such as FEV(1), SaO(2,) pCO(2) or BMI, showed a statistically significant correlation with survival time. Subjects who walked < or =700 m had a lower cumulative survival (P=0.02). There was a statistically significant positive correlation between walking distance and SaO(2) at rest and after 12 min of walking (r=0.5, P=0.001; and r=0.5, P=0.04, respectively). There was no correlation between walking distance and pCO(2) at rest, BMI, FEV(1), or degree of change in SaO(2) during the walk test. This study demonstrates that in CF patients with end-stage lung disease, walking distance during a 12-min walk test is more informative with respect to survival than single parameters such as SaO(2,) pCO(2), FEV(1) or BMI.
Subject(s)
Cystic Fibrosis/physiopathology , Cystic Fibrosis/surgery , Lung Transplantation , Walking , Adolescent , Adult , Child , Cystic Fibrosis/mortality , Female , Humans , Male , Prognosis , Retrospective Studies , SpirometryABSTRACT
Surgical management of tuberculosis is uncommon in children. We report a case of a 14-month-old boy with miliary tuberculosis and recurrent pneumothorax due to cavities in the left lung. This boy had no previous medical history and was referred to our hospital for a severe pneumonia. Initial chest radiograph showed bilateral miliary pattern. Direct microscopy of gastric lavage showed the presence of tubercle bacilli, providing definitive diagnosis. In spite of effective medication, his status rapidly worsened. A cardiac resuscitation was followed by intubation, and he required high-pressure ventilation for four weeks. He developed left pneumothorax, for which several drainages were performed. Computed tomography revealed a huge cavern system involving the entire lingula and surrounded by the left pneumothorax. Eventually, a massive enlargement of the initial cavity necessitated a thoracotomy and wedge resection.
Subject(s)
Tuberculosis, Miliary/complications , Tuberculosis, Pulmonary/complications , Gastric Lavage , Humans , Infant , Male , Mycobacterium tuberculosis/isolation & purification , Pneumonectomy , Pneumothorax/diagnosis , Pneumothorax/etiology , Pneumothorax/surgery , Recurrence , Surgical Stapling , Thoracotomy , Tomography, X-Ray Computed , Treatment Outcome , Tuberculosis, Miliary/diagnosis , Tuberculosis, Miliary/microbiology , Tuberculosis, Miliary/surgery , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/microbiology , Tuberculosis, Pulmonary/surgeryABSTRACT
BACKGROUND: Granulysin produced by cytolytic T cells directly contributes to immune defense against tuberculosis (TB). We investigated granulysin as a candidate immune marker for childhood and adolescent TB. METHODS: Peripheral blood mononuclear cells (PBMC) from children and adolescents (1-17 years) with active TB, latent TB infection (LTBI), nontuberculous mycobacteria (NTM) infection and from uninfected controls were isolated and restimulated in a 7-day restimulation assay. Intracellular staining was then performed to analyze antigen-specific induction of activation markers and cytotoxic proteins, notably, granulysin in CD4(+) CD45RO(+) memory T cells. RESULTS: CD4(+) CD45RO(+) T cells co-expressing granulysin with specificity for Mycobacterium tuberculosis (Mtb) were present in high frequency in TB-experienced children and adolescents. Proliferating memory T cells (CFSE(low)CD4(+)CD45RO(+)) were identified as main source of granulysin and these cells expressed both central and effector memory phenotype. PBMC from study participants after TB drug therapy revealed that granulysin-expressing CD4(+) T cells are long-lived, and express several activation and cytotoxicity markers with a proportion of cells being interferon-gamma-positive. In addition, granulysin-expressing T cell lines showed cytolytic activity against Mtb-infected target cells. CONCLUSIONS: Our data suggest granulysin expression by CD4(+) memory T cells as candidate immune marker for TB infection, notably, in childhood and adolescence.
Subject(s)
Antigens, Differentiation, T-Lymphocyte/metabolism , Biomarkers/metabolism , CD4-Positive T-Lymphocytes/metabolism , Tuberculosis/immunology , Adolescent , CD4-Positive T-Lymphocytes/immunology , Child , Child, Preschool , Female , Humans , Immunologic Memory , Infant , MaleABSTRACT
Chronic mucocutaneous candidiasis disease (CMCD) may be caused by autosomal dominant (AD) IL-17F deficiency or autosomal recessive (AR) IL-17RA deficiency. Here, using whole-exome sequencing, we identified heterozygous germline mutations in STAT1 in 47 patients from 20 kindreds with AD CMCD. Previously described heterozygous STAT1 mutant alleles are loss-of-function and cause AD predisposition to mycobacterial disease caused by impaired STAT1-dependent cellular responses to IFN-γ. Other loss-of-function STAT1 alleles cause AR predisposition to intracellular bacterial and viral diseases, caused by impaired STAT1-dependent responses to IFN-α/ß, IFN-γ, IFN-λ, and IL-27. In contrast, the 12 AD CMCD-inducing STAT1 mutant alleles described here are gain-of-function and increase STAT1-dependent cellular responses to these cytokines, and to cytokines that predominantly activate STAT3, such as IL-6 and IL-21. All of these mutations affect the coiled-coil domain and impair the nuclear dephosphorylation of activated STAT1, accounting for their gain-of-function and dominance. Stronger cellular responses to the STAT1-dependent IL-17 inhibitors IFN-α/ß, IFN-γ, and IL-27, and stronger STAT1 activation in response to the STAT3-dependent IL-17 inducers IL-6 and IL-21, hinder the development of T cells producing IL-17A, IL-17F, and IL-22. Gain-of-function STAT1 alleles therefore cause AD CMCD by impairing IL-17 immunity.
Subject(s)
Candidiasis, Chronic Mucocutaneous/genetics , Candidiasis, Chronic Mucocutaneous/immunology , Interleukin-17/immunology , Models, Molecular , STAT1 Transcription Factor/genetics , T-Lymphocytes/immunology , Base Sequence , Electrophoretic Mobility Shift Assay , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Fluorescent Antibody Technique , Germ-Line Mutation/genetics , Humans , Immunoblotting , Interferon-gamma/blood , Interferon-gamma/metabolism , Interferons , Interleukins/metabolism , Male , Molecular Sequence Data , Pedigree , Phosphorylation , Receptor, Interferon alpha-beta/immunology , STAT1 Transcription Factor/chemistry , STAT1 Transcription Factor/metabolism , Sequence Alignment , Sequence Analysis, DNAABSTRACT
Engagement of cytokine receptors by specific ligands activate Janus kinase-signal transducer and activator of transcription (STAT) signaling pathways. The exact roles of STATs in human lymphocyte behavior remain incompletely defined. Interleukin (IL)-21 activates STAT1 and STAT3 and has emerged as a potent regulator of B cell differentiation. We have studied patients with inactivating mutations in STAT1 or STAT3 to dissect their contribution to B cell function in vivo and in response to IL-21 in vitro. STAT3 mutations dramatically reduced the number of functional, antigen (Ag)-specific memory B cells and abolished the ability of IL-21 to induce naive B cells to differentiate into plasma cells (PCs). This resulted from impaired activation of the molecular machinery required for PC generation. In contrast, STAT1 deficiency had no effect on memory B cell formation in vivo or IL-21-induced immunoglobulin secretion in vitro. Thus, STAT3 plays a critical role in generating effector B cells from naive precursors in humans. STAT3-activating cytokines such as IL-21 thus underpin Ag-specific humoral immune responses and provide a mechanism for the functional antibody deficit in STAT3-deficient patients.
Subject(s)
Cell Differentiation/physiology , Immunologic Memory/physiology , Interleukins/immunology , Plasma Cells/immunology , STAT3 Transcription Factor/immunology , Signal Transduction/physiology , Antibody Formation/physiology , Antigens/genetics , Antigens/immunology , Humans , Immunoglobulins/genetics , Immunoglobulins/immunology , Interleukins/genetics , Plasma Cells/cytology , STAT1 Transcription Factor/genetics , STAT1 Transcription Factor/immunology , STAT3 Transcription Factor/genetics , Time FactorsABSTRACT
The incidence of childhood tuberculosis continues to decline in central Europe, but due to migration from high incidence countries paediatricians will still be confronted with it. The management of childhood tuberculosis in low-incidence, high-income countries differs from most high-incidence countries. The primary measures for preventing the transmission of tuberculosis to children are the detection of adult source cases, detection of latent TB infection (LTBI) in children by history, tuberculin skin testing and, if necessary and recommended, interferon-gamma release assays. Children with LTBI should receive preventive therapy. The inclusion of tuberculosis in the differential diagnosis of unclear pulmonary and extrapulmonary disease remains important, and tuberculosis has to be managed according to international standards.
Subject(s)
Tuberculosis, Pulmonary/therapy , Tuberculosis/therapy , Antitubercular Agents/administration & dosage , Antitubercular Agents/adverse effects , Chemoprevention , Child , Clinical Protocols , Humans , Immunoassay/methods , Incidence , Macrophages, Alveolar/microbiology , Mycobacterium tuberculosis/isolation & purification , Sensitivity and Specificity , Sputum/microbiology , Tuberculin Test , Tuberculosis/diagnosis , Tuberculosis/drug therapy , Tuberculosis/epidemiology , Tuberculosis/transmission , Tuberculosis, Multidrug-Resistant , Tuberculosis, Pulmonary/drug therapy , Tuberculosis, Pulmonary/epidemiology , Tuberculosis, Pulmonary/transmissionABSTRACT
The role of CD8(+) T cells in human tuberculosis (TB) remains elusive. We analyzed the T cell repertoire and phenotype in 1) children with active TB (< or =4 years), 2) healthy latently Mycobacterium tuberculosis-infected children, and 3) noninfected age-matched (tuberculin skin test-negative) controls. Ex vivo phenotyping of T cell subpopulations by flow cytometry revealed a significant increase in the proportion of CD8(+)CD45RO(-)CD62L(-)CD28(-)CD27(-) effector T cells (T(EF)) in the peripheral blood of children with active TB (22.1 vs 9.5% in latently M. tuberculosis-infected children, vs 8.5% in tuberculin skin test-negative controls). Analyses of TCR variable beta-chains revealed markedly skewed repertoires in CD8(+) T(EF) and effector memory T cells. Expansions were restricted to single TCR variable beta-chains in individual donors indicating clonal growth. CDR3 spectratyping and DNA sequencing verified clonal expansion as the cause for CD8(+) effector T cell enrichment in individual TB patients. The most prominent enrichment of highly similar T(EF) clones (>70% of CD8(+) T(EF)) was found in two children with active severe TB. Therefore, clonal expansion of CD8(+) T(EF) occurs in childhood TB with potential impact on course and severity of disease.